Drug · DIN 02494248
FLUCELVAX QUAD
SINGLE-DOSE PREFILLED SYRINGE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 30, 2025; first marketed September 21, 2020.
- Drug Identification Number (DIN)
- 02494248
- Company (DIN owner)
- Seqirus Uk LimitedMaidenhead, Berkshire, United Kingdom
- Schedule
- Schedule D
- Dosage form
- Suspension
- Route
- Intramuscular
- Therapeutic class (ATC)
- Influenza, inactivated, split virus or surface antigen J07BB02
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HAEMAGGLUTININ-STRAIN A (H1N1) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN A (H3N2) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN B (VICTORIA) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN B (YAMAGATA) | 15 MCG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 22, 2019: NOC 22932New Drug Submission (NDS)
Other DINs named FLUCELVAX QUAD
- DIN 02494256 · Approved